Your browser doesn't support javascript.
loading
Targeted DNA oxidation by LSD1-SMAD2/3 primes TGF-ß1/ EMT genes for activation or repression.
Pezone, Antonio; Taddei, Maria Letizia; Tramontano, Alfonso; Dolcini, Jacopo; Boffo, Francesca Ludovica; De Rosa, Mariarosaria; Parri, Matteo; Stinziani, Stefano; Comito, Giuseppina; Porcellini, Antonio; Raugei, Giovanni; Gackowski, Daniel; Zarakowska, Ewelina; Olinski, Ryszard; Gabrielli, Armando; Chiarugi, Paola; Avvedimento, Enrico Vittorio.
Afiliación
  • Pezone A; Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Istituto di Endocrinologia ed Oncologia Sperimentale del CNR, Università Federico II, 80131 Napoli, Italy.
  • Taddei ML; Dipartimento di Medicina Sperimentale e Clinica, Università degli Studi di Firenze, viale Morgagni 50, 50134 Firenze, Italy.
  • Tramontano A; Department of Precision Medicine, University of Campania "L. Vanvitelli'', 80138, Naples, Italy.
  • Dolcini J; Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Istituto di Endocrinologia ed Oncologia Sperimentale del CNR, Università Federico II, 80131 Napoli, Italy.
  • Boffo FL; Dipartimento di Scienze Cliniche e Molecolari, Clinica Medica, Università Politecnica delle Marche, 60100, Ancona, Italy.
  • De Rosa M; Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Istituto di Endocrinologia ed Oncologia Sperimentale del CNR, Università Federico II, 80131 Napoli, Italy.
  • Parri M; Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Istituto di Endocrinologia ed Oncologia Sperimentale del CNR, Università Federico II, 80131 Napoli, Italy.
  • Stinziani S; Dipartimento di Scienze Biomediche, Sperimentali e Cliniche, Università degli Studi di Firenze, viale Morgagni 50, 50134 Firenze, Italy.
  • Comito G; Dipartimento di Scienze Biomediche, Sperimentali e Cliniche, Università degli Studi di Firenze, viale Morgagni 50, 50134 Firenze, Italy.
  • Porcellini A; Dipartimento di Scienze Biomediche, Sperimentali e Cliniche, Università degli Studi di Firenze, viale Morgagni 50, 50134 Firenze, Italy.
  • Raugei G; Dipartimento di Biologia, Università Federico II, 80131 Napoli, Italy.
  • Gackowski D; Dipartimento di Scienze Biomediche, Sperimentali e Cliniche, Università degli Studi di Firenze, viale Morgagni 50, 50134 Firenze, Italy.
  • Zarakowska E; Department of Clinical Biochemistry, Faculty of Pharmacy, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, 85-095 Bydgoszcz, Poland.
  • Olinski R; Department of Clinical Biochemistry, Faculty of Pharmacy, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, 85-095 Bydgoszcz, Poland.
  • Gabrielli A; Department of Clinical Biochemistry, Faculty of Pharmacy, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, 85-095 Bydgoszcz, Poland.
  • Chiarugi P; Dipartimento di Scienze Cliniche e Molecolari, Clinica Medica, Università Politecnica delle Marche, 60100, Ancona, Italy.
  • Avvedimento EV; Dipartimento di Scienze Biomediche, Sperimentali e Cliniche, Università degli Studi di Firenze, viale Morgagni 50, 50134 Firenze, Italy.
Nucleic Acids Res ; 48(16): 8943-8958, 2020 09 18.
Article en En | MEDLINE | ID: mdl-32697292
ABSTRACT
The epithelial-to-mesenchymal transition (EMT) is a complex transcriptional program induced by transforming growth factor ß1 (TGF-ß1). Histone lysine-specific demethylase 1 (LSD1) has been recognized as a key mediator of EMT in cancer cells, but the precise mechanism that underlies the activation and repression of EMT genes still remains elusive. Here, we characterized the early events induced by TGF-ß1 during EMT initiation and establishment. TGF-ß1 triggered, 30-90 min post-treatment, a nuclear oxidative wave throughout the genome, documented by confocal microscopy and mass spectrometry, mediated by LSD1. LSD1 was recruited with phosphorylated SMAD2/3 to the promoters of prototypic genes activated and repressed by TGF-ß1. After 90 min, phospho-SMAD2/3 downregulation reduced the complex and LSD1 was then recruited with the newly synthesized SNAI1 and repressors, NCoR1 and HDAC3, to the promoters of TGF-ß1-repressed genes such as the Wnt soluble inhibitor factor 1 gene (WIF1), a change that induced a late oxidative burst. However, TGF-ß1 early (90 min) repression of transcription also required synchronous signaling by reactive oxygen species and the stress-activated kinase c-Jun N-terminal kinase. These data elucidate the early events elicited by TGF-ß1 and the priming role of DNA oxidation that marks TGF-ß1-induced and -repressed genes involved in the EMT.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: ADN / Proteína Smad2 / Factor de Crecimiento Transformador beta1 / Histona Demetilasas / Transición Epitelial-Mesenquimal Límite: Humans Idioma: En Revista: Nucleic Acids Res Año: 2020 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: ADN / Proteína Smad2 / Factor de Crecimiento Transformador beta1 / Histona Demetilasas / Transición Epitelial-Mesenquimal Límite: Humans Idioma: En Revista: Nucleic Acids Res Año: 2020 Tipo del documento: Article País de afiliación: Italia